Tweeter button Delicious button Digg button Stumbleupon button
Monthly Archives: March 2014
Hepatitis | Hepatitis C Outbreak A Mystery

The outbreak was discovered last year in Minot.Jim Olson has been investigating the Minot Hepatitis Mystery and has a series of reports this week.44 people have been confirmed as having the exact same strain of Hepatitis-C…meaning all the cases came from the same source.Except medical investigators say they have no idea what that source was.The North Dakota Department of Health has issued a    .. more …

Facebook Twitter Email

Posted on March 25, 2014, 8:09 pm By
Categories: hepatitis Tags:
Liver Disease | ‘Scandal’ Of Liver Disease Inaction

The lack of action to tackle liver disease in the UK is “scandalous” according to a group of MPs. In a report , the all-party Parliamentary Hepatology Group says deaths from liver disease in England have risen 40% between 2001-2012.It argues continuing complacency is leading to a “shameful waste of lives”. Liver disease accounts for the fifth highest number of deaths in the UK, but is the only one    .. more …

Facebook Twitter Email

Liver Cancer | Bayer's Nexavar Misses Target In Liver Cancer Trial

* Misses target in trial as an adjuvent therapy* Already approved to treat kidney and liver cancer* Shares down 0.3 percent vs 0.2 pct gain for DAXFRANKFURT, March 11 (Reuters) – Germany’s Bayer said a final stage Phase III clinical trial of cancer drug Nexavar as an adjuvant therapy for liver cancer did not meet its main target.Nexavar, or sorafenib, is made by Bayer and Onyx Pharmaceuticals, and    .. more …

Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.